Intrinsic Value of S&P & Nasdaq Contact Us

Ibotta, Inc. IBTA NYSE

NYSE • Technology • Software - Application • US • USD

SharesGrow Score
62/100
2/7 Pass
SharesGrow Intrinsic Value
$3,140.11
+9234.5%
Analyst Price Target
$26.00
-22.7%

Ibotta, Inc. (IBTA) is a Software - Application company in the Technology sector, currently trading at $33.64. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of IBTA = $3,140.11 (+9234.5% from the current price, the stock appears undervalued). Analyst consensus target is IBTA = $26 (-22.7% upside).

Valuation: IBTA trades at a trailing Price-to-Earnings (P/E) of 228.1 (S&P 500 average ~25).

Financials: revenue is $342M, +20%/yr average growth. Net income is $4M, growing at +51.7%/yr. Net profit margin is 1% (thin). Gross margin is 78.1% (+1.5 pp trend).

Balance sheet: total debt is $26M against $288M equity (Debt-to-Equity (D/E) ratio 0.09, conservative). Current ratio is 1.96 (strong liquidity). Debt-to-assets is 4.8%. Total assets: $526M.

Analyst outlook: 8 / 9 analysts rate IBTA as buy (89%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 12/100 (Fail), Growth 100/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 60/100 (Partial), Future 58/100 (Partial), Income 30/100 (Fail).

$26.00
▼ 22.71% Downside
Average Price Target
The 12-month price target for Ibotta, Inc. is $26.00.

IBTA SharesGrow Score Overview

62/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 12/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 60/100
Gross margin is + market cap
FUTURE 58/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — IBTA

VALUE Fail
12/100
IBTA trades at a trailing Price-to-Earnings (P/E) of 228.1 (S&P 500 average ~25). Forward PEG -5.44 — Peter Lynch undervalued (≤1.0). Analyst consensus target is $26, implying -22.7% from the current price $34. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
IBTA: +20%/yr revenue is, +51.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
IBTA: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet IBTA: Debt-to-Equity (D/E) ratio 0.09 (conservative), Current ratio is 1.96 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
60/100
IBTA: Gross margin is 78.1% (+1.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 60/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
58/100
Analyst outlook: 8 / 9 analysts rate IBTA as buy (89%). Analyst consensus target is $26 (-22.7% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
IBTA: Net profit margin is 1%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range19.1-62.74
Volume181.97K
Avg Volume (30D)332.82K
Market Cap$954.26M
Beta (1Y)-1.19
Share Statistics
EPS (TTM)0.13
Shares Outstanding$28.37M
IPO Date2024-04-19
Employees886
CEOBryan W. Leach
Financial Highlights & Ratios
Revenue (TTM)$342.39M
Gross Profit$267.42M
EBITDA$9.98M
Net Income$3.58M
Operating Income$1.66M
Total Cash$186.61M
Total Debt$25.5M
Net Debt$-161.11M
Total Assets$525.91M
Price / Earnings (P/E)258.8
Price / Sales (P/S)2.79
Analyst Forecast
1Y Price Target$26.00
Target High$26.00
Target Low$26.00
Upside-22.7%
Rating ConsensusBuy
Analysts Covering9
Buy 89% Hold 11% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS4510511060

Price Chart

IBTA
Ibotta, Inc.  ·  NYSE
Technology • Software - Application
19.10 52WK RANGE 62.74
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message